Value of different diagnostic criteria for the irritable bowel syndrome among men and women

Journal of Clinical Gastroenterology

Volumn 42, Issue 2, 2008, Pages 160-166

  Hammer, Johann ^a   Talley, Nicholas J ^b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Female; Irritable bowel syndrome; Male; Sex; Symptom

Indexed keywords

ADULT; ARTICLE; BLOATING; CLINICAL FEATURE; CLINICAL PRACTICE; CONSTIPATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADULT; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SEX FACTORS;

EID: 38349089347     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181574d48     Document Type: Article

References (44)

1. Drossman DA, Thompson WG, Talley NJ, et al. Identification of subgroups of functional bowel disorders. Gastroenterol Int. 1990;3:159-172.
2. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002;360:555-564.
3. Longstreth GF. Irritable bowel syndrome: a multibillion-dollar problem. Gastroenterology. 1995;109:2029-2042.
4. Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995;109:1736-1741.
5. Heaton KW, O'Donnell LD, Braddon FM, et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology. 1992;102:1962-1967.
6. Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology. 1980;79:283-288.
7. Drossman DA, Li Z, Andruzzi E, et al. U.S. household survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-1580.
8. Talley NJ, Zinsmeister AR, VanDyke C, et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991;101:927-934.
9. Talley NJ. Diagnosing an irritable bowel: does sex matter? Gastroenterology. 1991;100:834-837.
10. Thompson WG. Gender differences in irritable bowel symptoms. Europ J Gastroenterol Hepatol. 1997;9:299-302.
11. Lee OY, Mayer EA, Schmulson M, et al. Gender-related differences in IBS symptoms. Am J Gastroenterol. 2001;96:2184-2193.
12. Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998;42:690-695.
13. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J of Gastroenterol. 2004;99:750-759.
14. Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand J Gastroenterol. 2002;37:294-298.
15. Taub E, Cuevas JL, Cook EW III, et al. Irritable bowel syndrome defined by factor analysis: gender and race comparisons. Dig Dis Sci. 1995;40:2647-2655.
16. Feine JS, Bushnell MC, Miron D, et al. Sex differences in the perception of noxious heat stimuli. Pain. 1991;44:255-262.
17. Berkley KJ. Sex differences in pain. Behav Brain Sci. 1997;20:371-380.
18. Andersson HI, Ejlertsson G, Leden I, et al. Chronic pain in a geographically defined general population: studies of differences in age, gender, social class, and pain localization. Clin J Pain. 1993;9:174-182.
19. Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut. 1996;39:299-305.
20. Whitehead WE. Patient Subgroups in irritable bowel syndrome that can be defined by symptoms evaluation and physical examination. Am J Med. 1999;107:33S-40S.
21. Camilleri M, Mayer EA, Drossman DA, et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther. 1999;13:1149-1159.
22. Talley NJ, VanZanten SV, Saez LR, et al. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001;15:525-537.
23. Camilleri M. Review article: Tegaserod. Aliment Pharmacol Ther. 2001;15:277-289.
24. Chial HJ, Camilleri M. Gender differences in irritable bowel syndrome. J Gend Specif Med. 2002;5:37-45.
25. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94:5308-5313.
26. Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J. 1978;2:653-654.
27. Thompson WG, Creed F, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gastroenterol Int. 1992;5:75-91.
28. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45(suppl II):II43-II47.
29. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol. 2000;95:3176-3183.
30. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut. 1999;45(suppl 2):1-5.
31. Talley NJ, Phillips SF, Melton LJ III, et al. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989;111:671-674.
32. Hammer J, Eslick GD, Howell SC, et al. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut. 2004;53:666-672.
33. Eslick GD, Howell SC, Hammer J, et al. Empirically derived symptom sub-groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Aliment Pharmacol Ther. 2004;19:133-140.
34. Hammer J, Talley NJ. Disturbed bowel habits in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006;24:405-410.
35. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22:209-212.
36. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44:763-770.
37. Jones J, Boorman J, Cann P, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut. 2000;47(suppl II):ii1-ii19.
38. Talley NJ, Phillips SF, Melton LJ, et al. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut. 1990;31:77-81.
39. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.
40. Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med. 1999;107(suppl 1):5s-11s.
41. Chang L, Heitkemper MM. Gender difference in irritable bowel syndrome. Gastroenterology. 2002;123:1686-1701.
42. Sonnenberg A, Koch TR. Epidemiology of constipation in the United States. Dis Colon Rectum. 1989;32:1-8.
43. Everhart JE, Go VLW, Johannes RS, et al. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci. 1989;34:1143-1162.
44. Klonoff EA, Landrine H, Brown M. Appraisal and response to pain may be a function of its bodily location. J Psychosom Res. 1993;37:661-670.